Frequency of Hospitalized Infections Is Reduced in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs after 2010

<div>(a) Number of infections in the patients for whom a biological disease-modifying antirheumatic drug (bDMARD) was initiated each year. Open bars: the number of deaths in each year due to infections. Closed bars: the total number of infections for each year. (b) Cumulative incidence of hospitalized infections during the 3-year follow up, according to bDMARD.</div>

Journal of Immunology Research

fig3

Figure 3

Figure 3: Frequency of Hospitalized Infections Is Reduced in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs after 2010 

Figure 3 | Frequency of Hospitalized Infections Is Reduced in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs after 2010 